Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 16.2 mg (equivalent: folinic acid, qty 15 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections - leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 8.1 mg/ml equivalent to 7.5 mg folinic acid;  ;   - solution for injection - 15 mg/2ml - active: calcium folinate 8.1 mg/ml equivalent to 7.5 mg folinic acid     excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml;  ;   - solution for injection - 300 mg/30ml - active: calcium folinate 10.5 mg/ml     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 10.5 mg/ml (4% overage);  ;   - solution for injection - 50 mg/5ml - active: calcium folinate 10.5 mg/ml (4% overage)     excipient: sodium chloride water for injection - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired. use in combination with 5-fluorouracil in the treatment of advanced colorectal carcinoma.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - calcium folinate 18.6mg equivalent to folinic acid 15 mg - tablet - 15 mg - active: calcium folinate 18.6mg equivalent to folinic acid 15 mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose - calcium leucovorin has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. calcium leucovorin also has shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired.

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - calcium folinate - oral tablet - 15mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - calcium folinate - oral tablet - 15mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - calcium folinate - oral tablet - 15mg

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - calcium folinate - oral tablet - 15mg